(Reuters)—The average premium for benchmark 2017 Obamacare insurance plans sold on Healthcare.gov rose 25% compared with 2016, according to the U.S. government on Monday, the biggest increase since the insurance first went on sale in 2013 for the following year. The average monthly premium for the benchmark plan is rising to $302 from $242 in…
Denosumab Linked to Rebound-Associated Fractures in Nine Patients
NEW YORK (Reuters Health)—Patients can develop rebound-associated vertebral fractures after stopping denosumab, a new report of nine cases shows. All of the patients were considered to be at low risk of fracture, and the fractures occurred within nine to 16 months of their last injection, Dr. Olivier Lamy and colleagues from Lausanne University Hospital in Switzerland…
Spotlight on ACR Committee Appointments
At the American College of Rheumatology (ACR), volunteer leaders play an essential role in achieving the College’s goals in Advancing Rheumatology! This year, 64 new volunteers were appointed to serve on ACR Standing Committees. The College would like to extend a special thank you to these individuals who join other volunteer leaders in making a difference…
Choose the Right EHR the 1st Time
With so many electronic health record (EHR) systems on the market, it can be difficult to decide which one to choose. You may want to ask your peers for recommendations, visit practices that are using a system you’re contemplating and consider advice in trade journals. Jeffrey G. Lawson, MD, physician, Piedmont Arthritis Clinic, Greenville, S.C.,…
Brave New MACRA World
Sweeping changes in how physicians are paid for patient care are on the way. The Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act of 2015, or MACRA, tossed out the Sustainable Growth Rate formula and ties reimbursement to quality measures. A Helpful Presentation Because 2017 is the first performance year under the new…
UnitedHealth Sees More Growth in 2017 When It Exits Obamacare
(Reuters)—UnitedHealth Group Inc, the largest U.S. health insurer, on Tuesday raised the possibility of stronger profit growth in 2017 as it exits the government-subsidized insurance market commonly known as Obamacare, encouraging investors who have been negative on the sector. The company said losses in that business were within expectations in the third quarter, news that…
2015 Workforce Study Results: More Rheumatology Clinicians Needed
Will there be enough rheumatology clinicians available to treat a growing patient population in the future? Not unless serious steps are taken now, according to the American College of Rheumatology’s 2015 Workforce Study of Rheumatology Specialists in the United States. The study’s complete findings will be presented at a panel discussion session at the 2016…
State-of-the-Art Course on Interprofessional Management of Rheumatoid Arthritis
During an interactive, case-based course at the 2016 ACR/ARHP Annual Meeting, participants will develop strategies to help patients manage unique barriers to access to care and adherence…
Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology
Heraclitus of Ephesus (c. 500 BC) is credited with the saying, “The only constant is change.” Now, centuries later, change is meteoric, and especially in healthcare and health policy, the pace of change is relentless. Rheumatology and other specialties continue to face challenges that threaten the ability to deliver compassionate, competent care to patients. The…
Roche Gets Boost from FDA in Bid to Expand Uses for Actemra
ZURICH (Reuters)—The U.S. Food and Drug Administration has granted breakthrough status to Roche’s rheumatoid arthritis medication Actemra (tocilizumab) for giant cell arteritis, the Swiss drugmaker said, a step which could help it broaden applications for the medicine. Giant cell arteritis is a chronic, potentially life-threatening autoimmune condition caused by inflammation of large and medium-sized arteries,…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 153
- Next Page »